Form 8-K - Current report:
SEC Accession No. 0000950170-24-130415
Filing Date
2024-11-25
Accepted
2024-11-25 06:03:01
Documents
11
Period of Report
2024-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K onct-20241122.htm   iXBRL 8-K 45419
  Complete submission text file 0000950170-24-130415.txt   185386

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onct-20241122.xsd EX-101.SCH 45467
13 EXTRACTED XBRL INSTANCE DOCUMENT onct-20241122_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 241491777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)